Luckshi Rajendran
@lucksheee
Followers
322
Following
1K
Media
5
Statuses
390
Transplant and Hepatobiliary Surgery fellow @henryfordtxp; @uoftsurgery @ubcmedicine alums | MD, FRCSC, MEd | Art enthusiast, runner
Joined May 2012
ななにーの流出手に入れた 嘘ついて配らないやつ多すぎ もちろん無料で配ります いいねとRTのみ。フォロワーさん優先 #ななにー
2
0
0
Precision medicine in surgical treatment for patients with primary liver cancer - now in @LancetGastroHep 🔥 off the press and free accessible with my author link (until 12th of April 2025): https://t.co/vBOxSohrY0
1
2
3
Check out our published review on the role of LDLT in CRLM #hottopic #transplantoncology
@sapisochin
https://t.co/UAeQhrGs1D
0
1
7
Comparative analysis of treatment modalities for solitary, small (≤3 cm) hepatocellular carcinoma: A systematic review and network meta-analysis of oncologic outcomes https://t.co/2TdcR7U5vS Excellent OPEN ACCESS @SurgJournal publication from @UofT @UofTGSx @UofTNews @CAGS_ACCG
1
13
33
🏔️ A new milestone has been reached! 🔵 Out now in @TheLancet Transmet Trial 💥 Liver Transplantation + chemotherapy superior to chemo alone in permanently unresectable CRLM 📈 5-year overall survival 56·6% vs. 12.6% A new era has begun?! 🧐 https://t.co/aZ41e8jDVK
5
103
297
Thanks to all the amazing patients, surgeons, and researchers who made this trial possible. TXA did not reduce bleeding or blood transfusion but increased periop complications after liver resection. @JAMA_current
jamanetwork.com
This randomized clinical trial assesses the effect of tranexamic acid vs placebo on the need for blood transfusion among patients undergoing cancer-related liver resection.
11
28
100
Delighted to get our work accepted in the leading journal of transplantation @amjtransplant! Herein we tackle how long recipients of living donor liver transplantation survive, how survival has improved in recent eras and patient and center-factors associated with this.
"Temporal evolution of living donor liver transplantation survival – A UNOS registry study" by Magyar et al. https://t.co/gb9GCS99xu
1
3
17
Glad to be participating in a virtual symposium with @AST_LICOP re: Clinical Research Indication for Transplant Oncology in #ColorectalCancer co-chaired by @AShinginaMD @AnjanaPillaiMD @VUMC_Cancer @VUMCDiscoveries #cancer #CancerResearch #crcsm
0
7
21
We start the last session of the day on precision therapeutic strategies in biliary tract cancers. Dr. Gonzalo Sapisochin discusses the definition of resectable disease. #PrecisionBTCNet #ENSCCA #Krakow2024 🔬🇵🇱
0
4
13
Congrats to ON #GeneralSurgery PGY5+ grads of 2024 and welcome PGY1s!👏👏 We'd like your input on how we can better support you. Take our survey: https://t.co/92VDEh8gbJ | @Royal_College
@UofTSurgery @McMasterSurgery @western_gensurg @uOttawaGenSurg @QueensGenSurg @thenosm
0
2
1
Clinical impact of ctDNA to track minimal residual disease in CRC. Hopes and limitations @ESMO_Open
https://t.co/hvs95tE1A2 👏very comprehensive review 👉undeniable prognostic role, but still some work to do to intergrate as tool for optimal personalized treatment strategies
1
37
109
